. . . . . . . "[In summary, these findings suggest that PPAR? is involved in EPO/EPOR-induced AKT activation, and targeting the PPAR?/AKT pathway via EPO may have therapeutic implications for hepatic insulin resistance and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:20+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .